\
&
Contact us
\
&
Contact us
Published on | 2 years ago
Programmes MissionsThere are 2 attachments connected to this article.
Attachments are only accessible for people with an account on the NCP Flanders website.
The Commission has adopted an amendment to the ‘main’ Horizon Europe work programme 2023-2024.
The amended EU Missions work programme text (Version 2.0) and an overview of the details of the amendments can be found in attachment and have been made available on the Funding and Tender Portal under reference documents here.
Update to the EU Missions work programme 2023-2024 are:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
